$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trading has been observed in three US-listed companies: Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), ONEOK, Inc. (NYSE:OKE), and Landmark Bancorp, Inc. (NASDAQ:LARK). BB Biotech AG, a 10% owner of BDTX, acquired 1,740,000 shares for around $9.56 million. ONEOK's President and CEO, Pierce Norton, acquired 24,607 shares for around $1.5 million. Director Jim Lewis of LARK bought 1,427 shares for around $30,793.
June 30, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BB Biotech AG, a 10% owner of Black Diamond Therapeutics, Inc., acquired 1,740,000 shares for around $9.56 million.
The purchase of a significant number of shares by a 10% owner indicates strong confidence in the company's prospects, which could positively influence the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Director Jim Lewis of Landmark Bancorp, Inc. bought 1,427 shares for around $30,793.
The purchase of shares by a company director indicates confidence in the company's prospects, which could have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
ONEOK, Inc.'s President and CEO, Pierce Norton, acquired 24,607 shares for around $1.5 million.
The purchase of shares by the company's President and CEO indicates a strong belief in the company's future performance, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100